← Open Payments lookup

GWENDOLYN PRESTON: Open Payments

NPI 1053752485 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,693 in 52 payments from 9 companies in 2025. Trend: 2023 $831 · 2024 $28 · 2025 $1,693

Food & beverage: $1,693
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.13$460
Alkermes, Inc.9$374
ABBVIE INC.11$234
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$189
Teva Pharmaceuticals USA, Inc.4$165
Janssen Pharmaceuticals, Inc3$106
Otsuka America Pharmaceutical, Inc.3$88
Neurocrine BioSciences, Inc.1$40
Vanda Pharmaceuticals Inc.1$37

Products named: COBENFY, VRAYLAR, ARISTADA, CAPLYTA, UZEDY, LYBALVI, INVEGA SUSTENNA, ABILIFY MAINTENA.

Industry payments across CA — which companies pay providers there.